BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Pancreas
,
Nosology
,
Doxorubicin
,
rs4950928
,
MDM2
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mesylate
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Breast, endometrial and ovarian cancer cell lines treated with eribulin or paclitaxel
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid r…
Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent…
Nickel-catalyzed reductive coupling of arylcarboxylic acid 2-pyridyl esters with alkyl methanesulfon…
Cyclopropenone catalyzed substitution of alcohols with mesylate ion.
Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Stru…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Camrelizumab Combined With Apatinib Mesylate
Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stro…
Ipilimumab and Imatinib Mesylate in Advanced Cancer
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma
A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ